After baseline measurements , efficacy was assessed by echocardiography and single-photon emission computed tomography ( 6 , 12 , and 18 months ) , metabolic equivalents and maximal oxygen consumption ( MVO2 ) ( 6 and 18 months ) , and cardiac magnetic resonance imaging ( 6 months ) .